Tech Tour Announces the Top 20 Digital Health Companies and the Top 20 Medtech Companies in Europe

30 June - 1 July 2015, Lausanne, Switzerland.
The Tech Tour today announced the top 20 Digital Health companies and the top 20 Medtech companies in Europe. The 40 companies have been selected by two Selection Committees made up of Investors as well as representatives from Life Science companies. The selected companies will be presenting at the Healthtech Summit in Lausanne to an audience of over 200 people, including Venture and Private Equity investors collectively representing $40Bn in invested assets, Business Angels and Life Sciences companies, among whom the No 1 Pharma company, the No 1 food company and No 1 Med Tech company.

Close to 200 nominations were received, 123 companies have applied and the Selection Committees have spent several months rigorously screening and choosing the final 40. Companies were chosen according to the uniqueness of their solutions, the strength of their business model, their capability to execute on the business plan and the quality and track record of their management teams.

Of the top 40 companies, 4 are seed stage; 21 are start-ups; 14 are in expansion/growth stage and 1 company is late stage/pre-IPO. In terms of the countries represented the breakdown is as follows: Denmark (1); Finland (1); France (3); Germany (7); Ireland (1); Israel (1); Italy (1); Netherlands (1); Portugal (1); Spain (4); Sweden (1); Switzerland (10); UK (5).

The top 20 Digital Health Companies:
Better Doc, Biovotion, BrainControl, Coimbra Genomics, Dacadoo, Dermosafe, Doctoralia, Emperra, Exovite, Genexyx, Giraff, Healthbank, NeurNation, Nutrino, Psious, Px Healthcare, SilverCloud, Systems Healthcare Solutions, TrialReach, XtremeVRI.

The top 20 Medtech Companies:
Adaptix, Admetsys, Aeon Scientific, Atlas Genetics, Bone Index, coramaze, CorWave, DBS System, EasyScan, Lambda Health System, LimFlow, Medical Adhesive Revolution, Mensia, NanoLive, Newronika, Oncgnostics, PathMaker, Precision Ocular, Tissot Medical Research, Wise.

Speakers and panellists at the event include Ulrich Muehlner, Novartis, Valerio Nannini, Nestle, Bill Taranto and Joe Volpe, Global Health Innovation (Merck), Roberto Ascione, Razorfish Healthware, Martin Kelly, HealthXL, Toby Lewis, Global Corporate Venturing, Charity Kufaas, Medtronix, Angelo de Rosa, Boston Scientific, Janke Dittmer, Gilde Healthcare Partners, Bettina Experton, Humetrix and Victor Garcia, Mooreland Partners, as well asAlex Osterwalder, Strategyzer.

This year's Awards Ceremony will be held on June 30th at IMD with two award categories to recognize and celebrate excellence in health technology innovation. The new Canton de Vaud Digital Health Award will recognize one of the most promising innovative companies of the region with demonstrated market traction and fundraising. And this year's Salus Partners Excellence in Healthcare Award will go to the most successful company exit of the year among the 100+ Alumni of the HealthTech Summit.

For further information, please visit:
http://www.techtour.com/health_tech_summit_2015/

2015 Digital Health Selection Committee Members
Asset Management, Bessemer Venture Partners, Boston Scientific, DFJ Esprit, Endeavour Vision S.A., Gilde Healthcare Partners, Health XL, Index Ventures, Invesco Perpetual, Merck Global Health Innovation Fund, Medtronic Europe S.A., Mooreland Partners, Nestlé S.A., Norwest Venture Partners, Omega Funds, Orbimed Advisors, PHS Fund, Reed Elsevier Ventures, Samsung Electronics, SMR Capital, Startup Health.

2015 Medtech Selection Committee Members
Baycity Capital, Delta Partners Ltd., Earlybird Venture Capital, Endeavour Vision, Entrepreneurs Fund Management, Fountain Healthcare Partners, Imperial Innovations, NBGI Ventures, Omnes Capital, Salus Partners, Sofimac Partners Investment Capital, Sofinnova.

About The Tech Tour
The Tech Tour was founded in Geneva in 1998 in response to the growing interest in emerging technology companies in various European regions. The Tech Tour brings together investors and high-tech entrepreneurs through its highly successful events - Regional Tech Tours that cover multiple cities in a particular European region and Tech Summits that focus on a particular industry vertical. The Tech Tour focuses on selecting the highest quality companies for its events and as a result selected companies have been very successful in obtaining funding. The Tech Tour over the years has built a very strong and inter-connected community of Entrepreneurs, Investors, Government influencers, Industry experts and Advisers. This community comes together regularly to network, collaborate and to invest their time and money in furthering the high-tech innovation ecosystem in Europe.

About the International Venture Club
The International Venture Club was founded in 2011 as the collaborative platform of leading venture investors promoting successful international investments. Its objectives are to 1) share better practices, 2) build co-investor trust and relations, 3) foster new funding and investment opportunities through joint actions and PR, 4) grow promising companies with corporate partners and co-investors and 5) keep a smart window and support to emerging innovative companies.

Most Popular Now

Stanford Medicine Study Suggests Physici…

Artificial intelligence-powered chatbots are getting pretty good at diagnosing some diseases, even when they are complex. But how do chatbots do when guiding treatment and care after the diagnosis? For...

OmicsFootPrint: Mayo Clinic's AI To…

Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast amounts of complex biological data into two-dimensional circular images. The details of the tool...

Testing AI with AI: Ensuring Effective A…

Using a pioneering artificial intelligence platform, Flinders University researchers have assessed whether a cardiac AI tool recently trialled in South Australian hospitals actually has the potential to assist doctors and...

Adults don't Trust Health Care to U…

A study finds that 65.8% of adults surveyed had low trust in their health care system to use artificial intelligence responsibly and 57.7% had low trust in their health care...

AI Unlocks Genetic Clues to Personalize …

A groundbreaking study led by USC Assistant Professor of Computer Science Ruishan Liu has uncovered how specific genetic mutations influence cancer treatment outcomes - insights that could help doctors tailor...

The 10 Year Health Plan: What do We Need…

Opinion Article by Piyush Mahapatra, Consultant Orthopaedic Surgeon and Chief Innovation Officer at Open Medical. There is a new ten-year plan for the NHS. It will "focus efforts on preventing, as...

Deep Learning to Increase Accessibility…

Coronary artery disease is the leading cause of death globally. One of the most common tools used to diagnose and monitor heart disease, myocardial perfusion imaging (MPI) by single photon...

People's Trust in AI Systems to Mak…

Psychologists warn that AI's perceived lack of human experience and genuine understanding may limit its acceptance to make higher-stakes moral decisions. Artificial moral advisors (AMAs) are systems based on artificial...

DMEA 2025 - Innovations, Insights and Ne…

8 - 10 April 2025, Berlin, Germany. Less than 50 days to go before DMEA 2025 opens its doors: Europe's leading event for digital health will once again bring together experts...

Relationship Between Sleep and Nutrition…

Diet and sleep, which are essential for human survival, are interrelated. However, recently, various services and mobile applications have been introduced for the self-management of health, allowing users to record...

New AI Tool Mimics Radiologist Gaze to R…

Artificial intelligence (AI) can scan a chest X-ray and diagnose if an abnormality is fluid in the lungs, an enlarged heart or cancer. But being right is not enough, said...

AI Model can Read ECGs to Identify Femal…

A new AI model can flag female patients who are at higher risk of heart disease based on an electrocardiogram (ECG). The researchers say the algorithm, designed specifically for female patients...